Search for: "Merck & Co, Inc. v. United States" Results 121 - 140 of 168
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Nov 2009, 2:37 pm
United States and here for Merck & Co., Inc. v. [read post]
30 Nov 2009, 6:04 am
At 11 a.m., the Court will consider the deadline for filing securities fraud lawsuits in Merck & Co., Inc. v. [read post]
30 Nov 2009, 6:01 am
Wilson (08-304) â€" scope of right to sue to recover false claims against the federal government Merck & Co., Inc. v. [read post]
29 Nov 2009, 2:09 pm
In No. 08-905, Merck & Co., Inc. v. [read post]
28 Sep 2009, 12:53 pm
Wilson (08-304) – scope of right to sue to recover false claims against the federal government Merck & Co., Inc., et al. v. [read post]
2 Sep 2009, 11:22 pm
Merck & Co., 949 A.2d 223, 271-76 (N.J. [read post]
15 Apr 2009, 4:44 am
United Illuminating, 1998 WL 910271, at *10 (Conn. [read post]
20 Mar 2009, 2:05 am
United States, 880 F.2d 84, 86-87 (8th Cir. 1989).Kansas: Savina v. [read post]
23 Feb 2009, 2:41 am
Cardiologists implanted a covered stent manufactured by NuMed, Inc., a New York corporation that is one of the few developers of pediatric medical devices in the United States. [read post]
19 Feb 2009, 12:55 am
However, by opinion dated January 30, 2009, the United States Court of Appeals for the Third Circuit, relying on a recent decision in In re Merck & Co., Securities Derivative, & ‘ERISA’ Litigation, 543 F. 3d 150 (3d Cir. 2008), reversed the District Court. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years… [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46)   Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles)   Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise mechanisms for… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ… [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]